Cases with nuclear p14ARF overexpression
| Case no. . | Diagnosis . | p53 gene . | p53 (%) . | Hdm2 (%) . | Ki67 (%) . |
|---|---|---|---|---|---|
| 3 | DLBCL | C135F | 100 | 10 | 100 |
| 6 | DLBCL | R158H | 60 | 30 | 80 |
| 13 | BL | WT | NA | 50 | 100 |
| 21 | BL | WT | 100 | 30 | 95 |
| 26 | DLBCL | G245S | 100 | 0 | 90 |
| 34 | BL | WT | 60 | 80 | 95 |
| 36 | DLBCL | G244D | 80 | 10 | 95 |
| 46 | DLBCL | WT | 60 | 80 | 95 |
| 48 | DLBCL | V157F | 100 | 80 | 70 |
| 52 | DLBCL | NA | NA | NA | NA |
| 54 | DLBCL | NA | 20 | 20 | NA |
| 63 | DLBCL | NA | 60 | 40 | 40 |
| 67 | DLBCL | NA | 20 | 30 | 85 |
| 69 | DLBCL | NA | 40 | 100 | 75 |
| 72 | DLBCL | NA | 60 | 100 | 85 |
| 73 | DLBCL | NA | 10 | 50 | 85 |
| Case no. . | Diagnosis . | p53 gene . | p53 (%) . | Hdm2 (%) . | Ki67 (%) . |
|---|---|---|---|---|---|
| 3 | DLBCL | C135F | 100 | 10 | 100 |
| 6 | DLBCL | R158H | 60 | 30 | 80 |
| 13 | BL | WT | NA | 50 | 100 |
| 21 | BL | WT | 100 | 30 | 95 |
| 26 | DLBCL | G245S | 100 | 0 | 90 |
| 34 | BL | WT | 60 | 80 | 95 |
| 36 | DLBCL | G244D | 80 | 10 | 95 |
| 46 | DLBCL | WT | 60 | 80 | 95 |
| 48 | DLBCL | V157F | 100 | 80 | 70 |
| 52 | DLBCL | NA | NA | NA | NA |
| 54 | DLBCL | NA | 20 | 20 | NA |
| 63 | DLBCL | NA | 60 | 40 | 40 |
| 67 | DLBCL | NA | 20 | 30 | 85 |
| 69 | DLBCL | NA | 40 | 100 | 75 |
| 72 | DLBCL | NA | 60 | 100 | 85 |
| 73 | DLBCL | NA | 10 | 50 | 85 |
DLBCL indicates diffuse large B-cell lymphoma; BL, Burkitt lymphoma; FL-3, follicular lymphoma grade 3; WT, wild type; NA, not available.